Catalyst Wire Dossier Catalyst Wire Dossier

panitumumab + irinotecan

· Amgen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for panitumumab + irinotecan, covering 2014-03-28 to 2014-03-28. Get the full timeline:

Most recent: Clinical Trial Update: SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial [Phase 2]

See pricing